(redirected from paroxysmal)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for paroxysm

Synonyms for paroxysm

a condition of anguished struggle and disorder

a violent, excruciating seizure of pain

Synonyms for paroxysm

a sudden uncontrollable attack

Related Words

References in periodicals archive ?
Thus, 30 patients with psychomotor retardation, 23 subjects with a psycho-speech disorder, 28 children with emotional and behavioral disorders (EBD) and 29 examinees with paroxysmal syndrome were included into the groups.
Paroxysmal tonic upgaze of childhood with co-existent absence epilepsy.
We think these data support radiofrequency ablation as a first-line treatment in patients with paroxysmal atrial fibrillation," said presenter Jens Nielsen, MD, professor of medicine, Aarhus University Hospital, Skejby, Denmark.
KEY WORDS: Paroxysmal Hemicrania, Trigeminal Autonomic Cephalgias, Indomethacin, Lamotrigine.
Results: At 24 weeks, in the paroxysmal AF stratum, 129 of 269 participants (48%) in the placebo group and 135 of 258 participants (52%) in the prescription group had a recurrent symptomatic AF or flutter event.
The CLARITY-AF study will rigorously evaluate the efficacy, safety and efficiency of the Biosense Webster NAVISTAR(R) THERMOCOOL(R) catheter with CARTO(R) 3 System guidance compared to the Medtronic Pulmonary Vein Ablation catheter(R) (PVAC(R)) with fluoroscopy for treating paroxysmal atrial fibrillation.
Epidemiology of benign paroxysmal positional vertigo: a population based study.
Dukkipati, Director of Mount Sinai's Experimental Electrophysiology Laboratory, performed the procedure on a 58-year old man with a history of paroxysmal AFib on September 15.
The pharmaceutical company derives all of its revenue from Soliris, which treats paroxysmal nocturnal hemoglobinuria (PNH).
The Award recognizes the scientific innovation represented by the complement-inhibition technology of Soliris, and the impact the drug is having on the lives of patients with paroxysmal nocturnal hemolglobinuria (PNH), a rare, debilitating and life-threatening blood disorder.
has announced that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMEA) adopted a positive opinion recommending marketing authorization for Soliris (eculizumab) for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH).
Eventually, she wrote, the dance grows into something "violent, paroxysmal.
Forty-eight hours later, the patient had paroxysmal atrial fibrillation and a temperature of 39[degrees]C, with severe hemodynamic and respiratory impairment.